Ken Calvert
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, what has Ken Calvert bought and sold in the last 12 months? Show the disclosed ranges and the filings.
Using 13F.ai, which stocks does Ken Calvert trade most often, and how did those trades do against the S&P 500?
Using 13F.ai, list Ken Calvert's recent trades alongside any government contracts, lobbying filings or bills involving the same companies, with dates.
Connect your AI · Plans and the 7-day free trial (card required)
Committees
The congressional committees and subcommittees this member sits on.
Loading…
Campaign money
What this member's campaign committees raised and spent in the latest election cycle, from reports filed with the Federal Election Commission.
| Raised | Spent | Cash on hand | Debts |
|---|---|---|---|
| $7,050,383 | $6,332,129 | $980,391 | $2,371 |
2026 cycle (January 2025 to December 2026), reports through Oct 14, 2026. Candidate page on FEC.gov ↗
2024 cycle: raised $8.1M, spent $7.9M, cash on hand $262.1K. FEC.gov ↗
Totals for the whole two-year cycle, not one election. Raised includes transfers between a candidate's own committees. Totals only: no individual donor is named or shown.
Net worth
2025 reportAn estimate from the member's annual financial disclosure, as a range. The form reports value ranges, not exact figures.
From the 2025 annual report: 16 assets and 10 liabilities listed. The range is wide because every asset and debt is counted at the lowest and highest end of its bracket.
| The form reports value brackets, not exact figures. Low counts every asset at the bottom of its bracket and every debt at the top; high is the reverse; the middle (midpoint estimate) uses the middle of every bracket. The range is wide because it adds up every bracket. | Report | |||||
|---|---|---|---|---|---|---|
| 2025 | -$91.6M | -$37.7M | $16.1M | 16 | 10 | PDF ↗ |
| 2024 | -$92.1M | -$38.1M | $15.9M | 16 | 10 | PDF ↗ |
| 2023 | -$92.1M | -$38.1M | $15.9M | 16 | 10 | PDF ↗ |
| 2022 | -$92.1M | -$37.9M | $16.3M | 17 | 11 | PDF ↗ |
| 2021 | -$15.2M | $3.3M | $21.8M | 17 | 13 | Amendment PDF ↗ |
| 2020 | -$14.2M | $6.2M | $26.6M | 19 | 13 | Amendment PDF ↗ |
| 2019 | -$3.7M | $10.8M | $25.3M | 19 | 10 | Amendment PDF ↗ |
| 2018 | -$4.6M | $8.0M | $20.6M | 17 | 10 | Amendment PDF ↗ |
| 2017 | -$4.7M | $7.4M | $19.6M | 18 | 10 | Amendment PDF ↗ |
| 2016 | -$1.5M | $4.8M | $11.1M | 16 | 9 | Amendment PDF ↗ |
| 2015 | -$1.5M | $4.8M | $11.1M | 14 | 9 | PDF ↗ |
Estimated from the member's annual disclosure: assets minus liabilities, using the reported value ranges. Excludes the primary residence. Not audited.
Trades
Every trade this member, their spouse or dependent children have disclosed, newest first unless you sort by another column.
No recent disclosed trades for this member.
Trades in companies under their committees' jurisdiction
Trades in a company whose industry falls under a committee or subcommittee this member sits on.
Loading…
Capitol Hires from Ken Calvert’s office
33 hiresLobbyists for public companies who say they once worked in Ken Calvert’s office, from their lobbying filings.
| The lobbying report (LDA form LD-2) that names this lobbyist and office, with a link to it. Report period is the quarter the report covers; Posted is the day it was filed or amended, which can be much later. The same lobbyist is named again on each quarterly report for the same client, so a row is shown once, from the newest report, with the number of filings that name them. | ||||
|---|---|---|---|---|
| FMS Fresenius Medical Care AG | Emily Murry | Leg. Aide | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 2 filings |
| VRTX Vertex Pharmaceuticals Incorporated | Emily Murry | Leg. Aid | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 12 filings |
| SRPT Sarepta Therapeutics, Inc. | Emily Murry | Leg. Aide | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| SNY Sanofi | Emily Murry | Leg. Aid | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| DGX Quest Diagnostics Incorporated | Emily Murry | Leg. Aide | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered.
Bills sponsored
The ten most recent bills and resolutions this member introduced.
Loading…
Recent votes
The latest recorded votes this member took part in, with how they voted.
Loading…
Votes on bills they sponsored
Recorded votes on the bills and resolutions this member introduced, newest first.
Loading…
Terms served
Each term in office, with the seat and party at the time.
| Jan 3, 2025 | Jan 3, 2027 (scheduled) | House | CA-41 | Republican |
| Jan 3, 2023 | Jan 3, 2025 | House | CA-41 | Republican |
| Jan 3, 2021 | Jan 3, 2023 | House | CA-42 | Republican |
| Jan 3, 2019 | Jan 3, 2021 | House | CA-42 | Republican |
| Jan 3, 2017 | Jan 3, 2019 | House | CA-42 | Republican |
| Jan 6, 2015 | Jan 3, 2017 | House | CA-42 | Republican |
| Jan 3, 2013 | Jan 3, 2015 | House | CA-42 | Republican |
| Jan 5, 2011 | Jan 3, 2013 | House | CA-44 | Republican |
| Jan 6, 2009 | Jan 3, 2011 | House | CA-44 | Republican |
| Jan 4, 2007 | Jan 3, 2009 | House | CA-44 | Republican |
| Jan 4, 2005 | Jan 3, 2007 | House | CA-44 | Republican |
| Jan 7, 2003 | Jan 3, 2005 | House | CA-44 | Republican |
| Jan 3, 2001 | Jan 3, 2003 | House | CA-43 | Republican |
| Jan 6, 1999 | Jan 3, 2001 | House | CA-43 | Republican |
| Jan 7, 1997 | Jan 3, 1999 | House | CA-43 | Republican |
| Jan 4, 1995 | Jan 3, 1997 | House | CA-43 | Republican |
| Jan 5, 1993 | Jan 3, 1995 | House | CA-43 | Republican |